| Market Capitalization (Millions $) |
3,123 |
| Shares
Outstanding (Millions) |
54 |
| Employees |
2,146 |
| Revenues (TTM) (Millions $) |
601 |
| Net Income (TTM) (Millions $) |
135 |
| Cash Flow (TTM) (Millions $) |
114 |
| Capital Exp. (TTM) (Millions $) |
35 |
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc is a publicly traded American pharmaceutical company founded in 1996 by Drs. Jack and Rex Zhang. The company is headquartered in Rancho Cucamonga, California and has a market capitalization of over $1 billion. Amphastar specializes in the development, manufacturing, and marketing of generic and proprietary injectable and inhalation products.
The company has more than 20 injectable products in its portfolio, which includes anesthesia, analgesics, anti-infectives, cardiovascular, and central nervous system agents. Amphastar's most significant revenue generating product is enoxaparin sodium injection, a generic version of Sanofi's anticoagulant Lovenox. This product accounts for more than 50% of the company's total revenue.
Additionally, Amphastar has branded products, such as Primatene Mist, an over-the-counter inhaler used for the treatment of asthma symptoms. The company also has a pipeline of innovative products, including products in clinical trials for diabetes, hypoglycemia, and severe allergies.
The company has three manufacturing facilities located in California, which are equipped with the latest manufacturing technology and conform to the highest regulatory standards of the FDA and the European Medicines Agency (EMA).
In addition to its manufacturing capabilities, Amphastar has a robust research and development team that is responsible for developing new products and improving existing products. The company invests heavily in research and development, spending around 20% of its revenue on these activities.
Amphastar has a global presence and has distribution partnerships in many countries, including the United States, Europe, and Asia. The company has a diverse customer base that includes hospitals, wholesalers, and distributors.
Amphastar is committed to corporate social responsibility and strives to reduce its impact on the environment. The company has implemented sustainability programs that focus on energy efficiency, water conservation, and waste management.
In summary, Amphastar Pharmaceuticals is a leading pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and proprietary injectable and inhalation products. With a wide range of products, an innovative pipeline, and a strong commitment to sustainability, Amphastar is poised for continued growth and success in the pharmaceutical industry.
Company Address: 11570 6th Street Rancho Cucamonga 91730 CA
Company Phone Number: 980-9484 Stock Exchange / Ticker: NASDAQ AMPH
| AMPH is expected to report next financial results on February 29, 2024. |
|
|
